Variant report
Variant | nsv870333 |
---|---|
Chromosome Location | chr13:69240970-69260985 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:12)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:12 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:69259880..69261273-chr13:69319408..69320273,7 | MCF-7 | breast: | |
2 | chr13:69259900..69260965-chr13:69319275..69320290,3 | MCF-7 | breast: | |
3 | chr13:69259897..69261382-chr13:69319281..69320393,15 | MCF-7 | breast: | |
4 | chr13:69258923..69261156-chr13:69263100..69265480,2 | K562 | blood: | |
5 | chr13:69254844..69257160-chr13:69257337..69259897,2 | K562 | blood: | |
6 | chr13:69259986..69260836-chr13:69285583..69286413,2 | MCF-7 | breast: | |
7 | chr13:69259973..69261382-chr13:69319364..69320393,8 | MCF-7 | breast: | |
8 | chr13:69254844..69257160-chr13:69257337..69259897,2 | K562 | blood: | |
9 | chr13:69258057..69262640-chr13:69318281..69322115,7 | MCF-7 | breast: | |
10 | chr13:69255286..69258231-chr13:69263633..69265493,2 | K562 | blood: | |
11 | chr13:69260117..69261169-chr13:69319440..69320437,6 | MCF-7 | breast: | |
12 | chr13:69260112..69260846-chr13:69285482..69286306,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534926649 | chr13:69247415-69247416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs557733878 | chr13:69247482-69247483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs76910076 | chr13:69247513-69247514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183202341 | chr13:69247519-69247520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs559411259 | chr13:69247522-69247523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs532941429 | chr13:69247536-69247537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187370027 | chr13:69247537-69247538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs191818006 | chr13:69247541-69247542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563436524 | chr13:69247572-69247573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs541920325 | chr13:69247586-69247587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs182553634 | chr13:69247591-69247592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs374740530 | chr13:69247630-69247631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs287372 | chr13:69247634-69247635 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs541728868 | chr13:69247646-69247647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs564650446 | chr13:69247760-69247761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs533659706 | chr13:69247764-69247765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs558228947 | chr13:69250618-69250619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs543854423 | chr13:69250670-69250671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs373541137 | chr13:69250734-69250735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560756516 | chr13:69250751-69250752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs150092900 | chr13:69250756-69250757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs529804155 | chr13:69250776-69250777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs567929868 | chr13:69250790-69250791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565574758 | chr13:69250795-69250796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs540177795 | chr13:69250854-69250855 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs78757405 | chr13:69250875-69250876 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs112889042 | chr13:69250910-69250911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs553143695 | chr13:69250916-69250917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs551306143 | chr13:69250935-69250936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs76354629 | chr13:69250937-69250938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs186159673 | chr13:69251019-69251020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs190529329 | chr13:69251023-69251024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs376681274 | chr13:69251225-69251226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs551793220 | chr13:69251269-69251270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs556552340 | chr13:69251363-69251364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs571665916 | chr13:69251381-69251382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs531031946 | chr13:69251392-69251393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs551056093 | chr13:69251401-69251402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs373358925 | chr13:69251407-69251408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs536829489 | chr13:69251425-69251426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs117743025 | chr13:69251429-69251430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs112432615 | chr13:69251479-69251480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs567190683 | chr13:69251518-69251519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs538957437 | chr13:69251583-69251584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs182958184 | chr13:69251587-69251588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs188140602 | chr13:69251588-69251589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs537562739 | chr13:69251632-69251633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554214730 | chr13:69251814-69251815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs574172848 | chr13:69251828-69251829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs145854410 | chr13:69251844-69251845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 22737080 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:69247400-69247800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr13:69250600-69252000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr13:69250800-69251000 | Enhancers | HSMM | muscle |
4 | chr13:69251000-69251400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr13:69251000-69252000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr13:69251200-69252200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr13:69252000-69253000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
8 | chr13:69252000-69253000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
9 | chr13:69252800-69253200 | Enhancers | Placenta Amnion | Placenta Amnion |
10 | chr13:69253000-69253200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr13:69253000-69253200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr13:69253000-69253400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
13 | chr13:69253200-69256400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
14 | chr13:69253200-69260200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
15 | chr13:69258400-69260200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
16 | chr13:69260200-69260600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
17 | chr13:69260200-69260800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
18 | chr13:69260200-69260800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
19 | chr13:69260200-69264600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr13:69260400-69260800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
21 | chr13:69260600-69261400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
22 | chr13:69260600-69262800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
23 | chr13:69260800-69262200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
24 | chr13:69260800-69262200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
25 | chr13:69260800-69262200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |